Results 91 to 100 of about 13,759 (198)

Clinical effects of Streptokinase in acute myocardial infarction

, 2003
Background: With respect to the efficacy of thrombolytic agents in the treatment of acute myocardial infarction, the present study was conducted on CCU patients in Shaheed Beheshti hospital in Kashan in 1999-2000.
Abdar Esfahani, M., Saffari, M., Samei, A., Abdoli, H.   +3 more
core  

PO08 | NEXT-GENERATION THROMBOLYTICS: ENGINEERING STREPTOKINASE FOR ENHANCED ACTIVITY AND REDUCED IMMUNOGENICITY

Bleeding, Thrombosis and Vascular Biology
Introduction. Streptokinase (SK) is a widely used thrombolytic agent, but its clinical utility is limited due to its high immunogenicity, which results in rapid inactivation by antibodies. This study aimed to engineer a truncated variant of streptokinase
Mehwish Kanwal
doaj  

Influence of adenylic nucleotides on the activating function of streptokinase

, 1987
The addition of ATP or 3,5-AMP (but not UTP, GTP, CTP, AMP, 2,3-AMP, ADP, inorganic pyrophosphate) at a final concentration of 10 - 1 M into streptokinase solution, pH 7.0 or 9.5, causes a dramatical inhibition of streptokinase-induced fibrinolysis.
Пыжова, Н.С., Вотяков, В.И., Votyakov, V.I., Pyzhova, N.S., Nikandrov, V.N., Никандров, В.Н.   +5 more
core  

Myocardial Infarction Management With Peripheral Streptokinase

, 1984
The early management of myocardial infarction (MI) is undergoing a new evolution. Aggressive treatment and new invasive modalities have brought improved prognosis to these patients.
Nocero, Michael A., Jr., Mayer, Gabriel, Story, William E., Seco, Jose E.   +3 more
core   +1 more source

In-Hospital Outcome of patients having Acute Myocardial Infarction with and without Streptokinase

Gomal Journal of Medical Sciences, 2009
Background: Acute myocardial infarction is the leading cause of death. Streptokinase is the most commonly used thrombolytic agent. This study was conducted to compare in-hospital outcome of patients with acute myocardial infarction receiving ...
Shimal Khan, Amjad Abrar, Abdur Rehman Abid, Tehmina Jan, Habibullah Khan   +4 more
doaj  

Development of an Immunoaffinity Method for Purification of Streptokinase

, 2020
Background: Streptokinase is a potent activator of plasminogen to plasmin, the enzyme that can solubilize the fibrin network in blood clots. Streptokinase is currently used in clinical medicine as a thrombolytic agent.
Ezat Asgarani, Mohammad Babashamsi, Zohreh Karimi, Ali Salimi   +3 more
core  

Bolus streptokinase administration in acute myocardial infarction: features of hypotensive reaction

Российский кардиологический журнал, 2005
Hypotension prevalence and severity was investigated in two regimens of streptokinase (SK) administration in acute myocardial infarction (AMI). Group I (n = 17) received intravenous SK, 0.75 mln IE, in 10 minutes; Group II (n = 9) - 1.5 mln IE, in 45 ...
V. A. Stolyarov, I. V. Maksimov, V. A. Markov   +2 more
doaj  

Anisoylated plasminogen streptokinase activator complex versus streptokinase in acute myocardial infarction. Preliminary results of a randomised study.

, 1987
25 patients with acute myocardial infarction pain lasting more than 20 minutes which was not relieved by nitrates, whose ECGs showed ST segment elevations of 1 mm or more in 2 or more ECG leads, and who presented less than 3 hours after onset of their ...
Grbic, M., Perret, C., Goy, J.J., Kaufmann, U., Kappenberger, L., Vincent, A., Bachmann, F., Badan, M., Monnier, P., Sigwart, U., Schaller, M.D.   +10 more
core   +1 more source

A Non-randomized Clinical Trial on the Effectiveness and Complications of Two Different Streptokinase Dosages in Elderly Patients With ST-Elevation Myocardial Infarction (STEMI). [PDF]

Cureus
Chandra S, Rai PJ, Singh N, Shivhare A.
europepmc   +1 more source

Thrombolysis for pulmonary embolism: A network meta-analysis. [PDF]

J Intensive Care Soc
Ross A, Glaister P, Robinson N, Crossingham I.   +3 more
europepmc   +1 more source